UXN
1 known investors
Find your way into UXN
Sign up to see every warm intro you have to UXN
- Paths you didn't know you had: your email and LinkedIn already hold routes to the UXN team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
UXN develops non-enzymatic blood glucose sensors based on nanoporous platinum electrodes, using electrochemical and biosensor technology for continuous, blood-draw-free glucose monitoring. The company also researches implantable glucose measurement technology for healthcare applications.
Investors · 1
Frequently asked questions
- What does UXN do?
- UXN develops non-enzymatic blood glucose sensors based on nanoporous platinum electrodes, using electrochemical and biosensor technology for continuous, blood-draw-free glucose monitoring. The company also researches implantable glucose measurement technology for healthcare applications.
- Who are UXN's investors?
- UXN's investors include Magna Investment.